相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity
Karl Nadolsky et al.
ENDOCRINE PRACTICE (2023)
Contemporary medical, device, and surgical therapies for obesity in adults
Carolina M. Perdomo et al.
LANCET (2023)
Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies
J. D. Watkins et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2023)
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial
Anna Veelen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2023)
Children and Adolescents: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906
Arvid Jungnik et al.
DIABETES OBESITY & METABOLISM (2023)
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Marlene Chakhtoura et al.
ECLINICALMEDICINE (2023)
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Ildiko Lingvay et al.
LANCET (2022)
Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity
Maria D. Ballesteros-Pomar et al.
NUTRITION (2022)
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update
Erik Stenberg et al.
WORLD JOURNAL OF SURGERY (2022)
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
Thomas Karagiannis et al.
DIABETOLOGIA (2022)
Epidemiological study on short and long-term weight loss with improvement of metabolic control in obese diabetic patients with a standardized multidisciplinary weight loss program (DIAMEX Study)
Francisco J. Nachon et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Evaluation of metabolic syndrome, insulin secretion and insulin resistance in adolescents with overweight and obesity
Yethindra Vityala et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitus
Angeliki Meritsi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Mahmoud M. Ali et al.
BMC ENDOCRINE DISORDERS (2022)
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
Tina Zimmermann et al.
MOLECULAR METABOLISM (2022)
What's preventing us from curbing the obesity crisis?
[Anonymous]
LANCET DIABETES & ENDOCRINOLOGY (2022)
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Eduardo Grunvald et al.
GASTROENTEROLOGY (2022)
Results of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health -Diabetes randomized controlled trial
Deborah J. Wexler et al.
OBESITY (2022)
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery
Dan Eisenberg et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2022)
Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial
Thomas A. Wadden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Leptin in Leanness and Obesity JACC State-of-the-Art Review
Nikolaos Perakakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial
Melanie Davies et al.
LANCET (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Domenica Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The Role of GIP Receptor in the CNS for the Pathogenesis of Obesity
Makoto Fukuda
DIABETES (2021)
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Rajaa Nahra et al.
DIABETES CARE (2021)
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Juan P. Frias et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
David C. D. Hope et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Metabolic Messengers: tumour necrosis factor
Jaswinder K. Sethi et al.
NATURE METABOLISM (2021)
Incretins in obesity and diabetes
Chee W. Chia et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Ricardo J. Samms et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases
Xin Su et al.
MOLECULAR BIOLOGY REPORTS (2020)
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Alison B. Evert et al.
DIABETES CARE (2019)
Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials
Navneet Singh et al.
BMJ OPEN (2019)
The pathogenesis of obesity
Sabrina M. Oussaada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity: seize the day, fight the fat
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Frank L. Greenway et al.
OBESITY (2019)
Sarcopenic obesity: Time to meet the challenge
Rocco Barazzoni et al.
CLINICAL NUTRITION (2018)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET (2018)
Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study
Ayse Sahin-Efe et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Inflammation: A key player linking obesity with malignancies
Chrysoula Boutari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari et al.
ENDOCRINOLOGY AND METABOLISM (2018)
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations
Francesco Rubino et al.
OBESITY SURGERY (2017)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux et al.
LANCET (2017)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Current body composition measurement techniques
Thaisa Lemos et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
A dipose tissue, obesity and non-alcoholic fatty liver disease
Stergios A. Polyzos et al.
MINERVA ENDOCRINOLOGICA (2017)
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
Edward W. Gregg et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M Apovian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improving diabetes outcomes through lifestyle change - A randomized controlled trial
Linda M. Delahanty et al.
OBESITY (2015)
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Chiara Saponaro et al.
NUTRIENTS (2015)
Lifestyle Weight-Loss Intervention Outcomes in Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Marion J. Franz et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2015)
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
William C. Hsu et al.
DIABETES CARE (2015)
Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
W. Timothy Garvey et al.
DIABETES CARE (2014)
Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
Lars Sjostrom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Gerald I. Shulman
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
Thomas A. Wadden et al.
OBESITY (2014)
Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
Sonja K. Billes et al.
PHARMACOLOGICAL RESEARCH (2014)
Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus
Chan-Hee Jung et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Inflammation during obesity is not all bad: evidence from animal and human studies
Jianping Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
T. A. Wadden et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Evaluation of Phentermine and Topiramate versus Phentermine/Topiramate Extended-Release in Obese Adults
Louis J. Aronne et al.
OBESITY (2013)
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
Caroline M. Apovian et al.
OBESITY (2013)
HYPOXIA AND ADIPOSE TISSUE FUNCTION AND DYSFUNCTION IN OBESITY
Paul Trayhurn
PHYSIOLOGICAL REVIEWS (2013)
Interleukin-6 and insulin resistance in obese adolescents
Raynald Takumansang et al.
PAEDIATRICA INDONESIANA (2013)
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
W. Timothy Garvey et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Adiponectin: mechanistic insights and clinical implications
A. T. Turer et al.
DIABETOLOGIA (2012)
Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
Edward W. Gregg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis
M. Ashwell et al.
OBESITY REVIEWS (2012)
Obesity, inflammation and the immune system
Fatima Perez de Heredia et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2012)
Gut microbiota and nonalcoholic fatty liver disease
Mariana V. Machado et al.
ANNALS OF HEPATOLOGY (2012)
Regulation of stem cell differentiation in adipose tissue by chronic inflammation
Jianping Ye et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde et al.
LANCET (2011)
Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
Thomas A. Wadden et al.
OBESITY (2011)
Correlation of Adiponectin and Leptin with Insulin Resistance: A Pilot Study in Healthy North Indian Population
Amita Yadav et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2011)
GIP-Dependent Expression of Hypothalamic Genes
S. Ambati et al.
PHYSIOLOGICAL RESEARCH (2011)
Hyperinsulinemia Precedes Insulin Resistance in Mice Lacking Pancreatic β-Cell Leptin Signaling
Sarah L. Gray et al.
ENDOCRINOLOGY (2010)
Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review
J. C. M. Barte et al.
OBESITY REVIEWS (2010)
Leptin in humans: lessons from translational research
Susann Blueher et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes
C. Daousi et al.
CLINICAL ENDOCRINOLOGY (2009)
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Alan Garber et al.
LANCET (2009)
Insulin Resistance and Hyperinsulinemia Is hyperinsulinemia the cart or the horse?
Michael H. Shanik et al.
DIABETES CARE (2008)
Relationship between adipocyte size and adipokine expression and secretion
Thomas Skurk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease
Stefan Pilz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Etiology of insulin resistance
KF Petersen et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Adiposity of the heart*, revisited
JM McGavock et al.
ANNALS OF INTERNAL MEDICINE (2006)
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
K Morino et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The interactions between inflammation and coagulation
CT Esmon
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
S Cinti et al.
JOURNAL OF LIPID RESEARCH (2005)
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes
KF Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions
D Kawanami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans
AF Pontiroli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries
S Verlohren et al.
HYPERTENSION (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Serum resistin (FIZZ3) protein is increased in obese humans
M Degawa-Yamauchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells
J St-Pierre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
MC Alessi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Mitochondrial dysfunction in the elderly: Possible role in insulin resistance
KF Petersen et al.
SCIENCE (2003)
Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans
M Yannakoulia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging
LS Szczepaniak et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the Lipid Research Clinics Study
J Stevens et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial
M Hanefeld et al.
DIABETES OBESITY & METABOLISM (2002)
Influence of leptin on arterial distensibility - A novel link between obesity and cardiovascular disease?
A Singhal et al.
CIRCULATION (2002)
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
JM Miles et al.
DIABETES CARE (2002)
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
K Miyawaki et al.
NATURE MEDICINE (2002)
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes - A 1-year randomized controlled trial
DE Kelley et al.
DIABETES CARE (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year
P Ziccardi et al.
CIRCULATION (2002)
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity
S Konstantinides et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men
TA Lakka et al.
ATHEROSCLEROSIS (2001)
分享论文
